NCT05553652View on ClinicalTrials.gov

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

NARecruitingINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

August 1, 2024

Study Completion Date

December 1, 2027

Conditions
Recurrent Urinary Tract Infection
Interventions
DIETARY_SUPPLEMENT

ASTARTE™ oral capsules

1 Capsule daily for 6 months

DIETARY_SUPPLEMENT

Placebo oral capsules

1 Capsule daily for 6 months

Trial Locations (1)

2650

RECRUITING

Gastrounit, Copenhagen University Hospital Hvidovre, Hvidovre

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER